METHODS	The trial was conducted on 3 consecutive phases ( co-administration of Asp Mg or placebo with BZD during 1 month ; gradual taper of BZD during 1 month ; follow-up during a third month after complete BZD discontinuation , with urinary BZD control on d75 and d90 ) .\